| [1] |
Adhami M, Michail P, Rao A, et al. Anti-thyroid antibodies and TSH as potential markers of thyroid carcinoma and aggressive behavior in patients with indeterminate fine-needle aspiration cytology[J]. World J Surg, 2020, 44(2): 363-370.
|
| [2] |
Fang Y, Sun F, Zhang RJ, et al. Mutation screening of the TSHR gene in 220 Chinese patients with congenital hypothyroidism[J]. Clin Chim Acta, 2019, 497: 147-152.
|
| [3] |
Stephen JK, Chen KM, Merritt J, et al. Methylation markers differentiate thyroid cancer from benign nodules[J]. J Endocrinol Invest, 2018, 41(2): 163-170.
|
| [4] |
Aliyev A, Gupta M, Nasr C, et al. Circulating thyroid-stimulating hormone rececptor messenger RNA as a marker of tumor aggressiveness in patients with papillary throid microcarcinnoma[J]. Endocr Pract, 2015, 21(7): 777-781.
|
| [5] |
Liu TR, Su X, Qiu WS, et al. Thyroid-stimulating hormone receptor affects metastasis and prognosis in papillary thyroid carcinoma[J]. Eur Rev Med Pharmacol Sci, 2016, 20(17): 3582-3591.
|
| [6] |
Rousseau-Merck MF, Misrahi M, Loosfelt H, et al. Assignment of the human thyroid stimulating hormone receptor (TSHR) gene to chromosome 14q31[J]. Genomics, 1990, 8(2): 233-236.
|
| [7] |
Cancer Genome Atlas Research Network. Integrated genomic characterization of papillary thyroid carcinoma[J]. Cell, 2014, 159(3): 676-690.
|
| [8] |
Kocsis-Deák B, Árvai K, Balla B, et al. Targeted mutational profiling and a powerful risk score as additional tools for the diagnosis of papillary thyroid cancer[J]. Pathol Oncol Res, 2020, 26(1): 101-108.
|
| [9] |
Neumann S, Krause G, Chey S, et al. A free carboxylate oxygen in the side chain of position 674 in transmembrane domain 7 is necessary for TSH receptor activation[J]. Mol Endocrinol, 2001, 15(8): 1294-1305.
|
| [10] |
Jaeschke H, Undeutsch H, Patyra K, et al. Hyperthyroidism and papillary thyroid carcinoma in thyrotropin receptor D633H mutant mice[J]. Thyroid, 2018, 28(10): 1372-1386.
|
| [11] |
Su X, Lin LW, Weng JL, et al. TSHR rs2288496 associated with thyroid hormone and predict the occurrence of lymph node metastasis of papillary thyroid cancer[J]. Cancer Biomark, 2019, 26(4): 461-470.
|
| [12] |
Kartal K, Onder S, Kosemehmetoglu K, et al. Methylation status of TSHr in well-differentiated thyroid cancer by using cytologic material[J]. BMC Cancer, 2015, 15(1): 824.
|
| [13] |
张晨, 霍倩, 李翠珍, 等. 促甲状腺激素受体基因甲基化与甲状腺乳头状癌关联的Meta分析[J]. 中国全科医学, 2013, 16(28): 3371-3375.
|
| [14] |
Mohammadi-asl J, Larijani B, Khorgami Z, et al. Qualitative and quantitative promoter hypermethylation patterns of the P16, TSHR, RASSF1A and RARβ2 genes in papillary thyroid carcinoma[J]. Med Oncol, 2011, 28(4): 1123-1128.
|
| [15] |
Chia SY, Milas M, Reddy SK, et al. Thyroid-stimulating hormone receptor messenger ribonucleic acid measurement in blood as a marker for circulating thyroid cancer cells and its role in the preoperative diagnosis of thyroid cancer[J]. J Clin Endocrinol Metab, 2007, 92(2): 468-475.
|
| [16] |
Liu R, Hao S, Zhang H, et al. Correlation of thyroid stimulating hormone receptor mRNA expression levels in peripheral blood with undesirable clinicopathological features in papillary thyroid carcinoma patients[J]. Oncotarget, 2017, 8(43): 74129-74138.
|
| [17] |
Aliyev A, Soundararajan S, Bucak E, et al. The utility of peripheral thyrotropin receptor mRNA in the management of differentiated thyroid cancer[J]. Surgery, 2015, 158(4): 1089-1093.
|
| [18] |
Wang ZF, Liu QJ, Liao SQ, et al. Expression and correlation of sodium/iodide symporter and thyroid stimulating hormone receptor in human thyroid carcinoma[J]. Tumori, 2011, 97(4): 540-546.
|
| [19] |
刘春萍, 楚慧敏, 明洁, 等. 促甲状腺激素受体及碘钠泵在人甲状腺癌中的表达及临床意义[J]. 解剖学报, 2008, 39(5): 756-759.
|
| [20] |
郝少龙, 马纪红, 刘新承, 等. 甲状腺乳头状癌组织TSHR表达与BRAFV600E基因突变的关系研究[J/CD]. 中华普外科手术学杂志(电子版), 2018, 12(6): 468-471.
|
| [21] |
Kim YH, Choi YW, Han JH, et al. TSH signaling overcomes B-RafV600E-induced senescence in papillary thyroid carcino-genesis through regulation of DUSP6[J]. Neoplasia, 2014, 16(12): 1107-1120.
|
| [22] |
Kleiman DA, Buitrago D, Crowley MJ, et al. Thyroid stimulating hormone increases iodine uptake by thyroid cancer cells during BRAF silencing[J]. J Surg Res, 2013, 182(1): 85-93.
|
| [23] |
Zhou C, Li J, Wang Y, et al. Association of BRAF gene and TSHR with cervical lymph node metastasis of papillary thyroid microcarcinoma[J]. Oncol Lett, 2019, 17(1): 183-194.
|
| [24] |
Zhou Q, Chen J, Feng J, et al. Long noncoding RNA PVT1 modulates thyroid cancer cell proliferation by recruiting EZH2 and regulating thyroid-stimulating hormone receptor (TSHR)[J]. Tumour Biol, 2016, 37(3): 3105-3113.
|
| [25] |
Shen CT, Qiu ZL, Song HJ, et al. miRNA-106a directly targeting RARB associates with the expression of Na(+)/I(-) symporter in thyroid cancer by regulating MAPK signaling pathway[J]. J Exp Clin Cancer Res, 2016, 35(1): 101.
|